Latest News - Becton Dickinson
Top Corporates Hub
Becton Dickinson
BD Launches Elyra Thulium Fiber Laser System for Kidney Stone Care
22.05.2026 14:13
BDX launches the Elyra Thulium Fiber Laser system to streamline kidney stone care and boost workflow flexibility for urology teams.
BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System
21.05.2026 10:50
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the introduction of the Elyra™ Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete BD's kidney stone care portfolio for urology teams. Designed to enhance efficiency, versatility, and procedural workflow across urologic stone management and soft tissue procedures, the innovative new system supports consistent performance in demanding clinical environments.
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
19.05.2026 10:05
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
19.05.2026 10:05
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.
Peter Menziuso Named EVP and President, BD Interventional
18.05.2026 06:51
FRANKLIN LAKES, N.J., May 18, 2026 /PRNewswire/ -- BD , a leading global medical technology company, today announced that Peter Menziuso has been named executive vice president and president, BD...
Peter Menziuso Named EVP and President, BD Interventional
18.05.2026 06:51
FRANKLIN LAKES, N.J., May 18, 2026 /PRNewswire/ -- BD , a leading global medical technology company, today announced that Peter Menziuso has been named executive vice president and president, BD...
Becton Dickinson (BDX) Delivers Solid Q2 Performance, Barclays Lifts Target
16.05.2026 09:54
Becton, Dickinson and Company (NYSE:BDX) is included among the 11 Best Rising Dividend Stocks to Buy Right Now. On May 11, Barclays raised its price recommendation on Becton, Dickinson and Company (NYSE:BDX) to $204 from $202. It reiterated an Overweight rating on the shares following the company’s fiscal Q2 results. The firm said Becton delivered […]
Did BD’s Earnings Shift, Portfolio Sale and New CFO Just Recast Becton Dickinson’s (BDX) Investment Narrative?
10.05.2026 02:12
In early May 2026, Becton, Dickinson and Company reported higher quarterly sales of US$4.71 billion but swung to a net loss, raised its full-year adjusted earnings guidance, completed the divestiture of its Biosciences & Diagnostic Solutions business, appointed long-time executive Vitor Roque as permanent CFO and executive vice president, and advanced new offerings and partnerships in medication management and vascular access. Beyond the headline earnings beat and guidance increase, BD’s...
Wells Fargo Maintains Equal-Weight on Becton Dickinson, Raises Price Target to $161
08.05.2026 09:20
Wells Fargo analyst Lawrence Biegelsen maintains Becton Dickinson (NYSE:BDX) with a Equal-Weight and raises the price target from $157 to $161.
BD’s (NYSE:BDX) Q1 CY2026 Sales Beat Estimates
07.05.2026 13:25
Medical technology company Becton, Dickinson and Company (NYSE:BDX) announced better-than-expected revenue in Q1 CY2026, with sales up 5.2% year on year to $4.71 billion. Its non-GAAP profit of $2.90 per share was 4.5% above analysts’ consensus estimates.
Becton Dickinson (BDX) Q2 Earnings and Revenues Surpass Estimates
07.05.2026 11:45
Becton Dickinson (BDX) delivered earnings and revenue surprises of +4.82% and +1.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
BDX (Becton Dickinson) Posts EPS Beat in Q2 2026, Pre-Market Rallies Despite Slight Revenue Miss
07.05.2026 11:32
BD reports fiscal Q2 2026 earnings with adjusted EPS of $2.90, beating estimates by 3.6%, and pre-market shares rise 2.24%.
Becton Dickinson stock gains after company lifts earnings outlook
07.05.2026 11:10
Investing.com -- Becton Dickinson shares climbed after the medical device maker beat second-quarter profit and revenue estimates and raised its full-year earnings guidance.
BD Appoints Vitor Roque Chief Financial Officer
07.05.2026 10:31
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Vitor Roque has been named executive vice president and chief financial officer (CFO), effective May 7. Roque has served as interim CFO since December 2025.
BD Reports Second Quarter Fiscal 2026 Financial Results
07.05.2026 10:30
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 second quarter, which ended March 31, 2026.
Transcript : Becton, Dickinson and Company, Q2 2026 Earnings Call, May 07, 2026
07.05.2026 10:05
Presentation Operator MessageOperator Hello, and welcome to BD's Second Fiscal Quarter 2026 Earnings Call. At the request of BD, today's call is being recorded and will be available for replay on
Becton, Dickinson and Company Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026
07.05.2026 09:06
Becton, Dickinson and Company reported earnings results for the second quarter and six months ended March 31, 2026. For the second quarter, the company reported sales was USD 4,714 million compared to...
Becton, Dickinson and Company 2026 Q2 - Results - Earnings Call Presentation
07.05.2026 08:36
2026-05-07. The following slide deck was published by Becton, Dickinson and Company in conjunction with their 2026 Q2 earnings call.
Embecta: A Sharp Decline On Q2 Earnings, But There's Still No Opportunity
07.05.2026 08:30
Embecta faces accelerating revenue declines, with Q2 2026 sales down 14% and U.S. revenues plunging 29%. Click here to read my earnings analysis of EMBC stock.
Becton, Dickinson and Company Appoints Vitor Roque as Chief Financial Officer, Effective May 7, 2026
07.05.2026 08:05
BD announced that Vitor Roque has been named chief financial officer , effective May 7, 2026. Roque has served as interim CFO since December 2025. With more than 25 years at BD, Roque has held senior...